Skip to main content

Table 2 Summary of National Surveillance Data of HIV Biomarkers

From: High coverage needle/syringe programs for people who inject drugs in low and middle income countries: a systematic review

Country Report Information Coverage Pre Implementation and Expansion Post Implementation and Expansion
Investigators Location Surveillance Method Syringes per PWID/Year1 Year Baseline HIV cases (n) Year Follow-up2HIV cases (n) (Percent Change)
CDC 2007 [32] Iran National Surveillance Data 4-41 2003 2332 2007 426 (82%)
Astrauskiene 2010 [33] Lithuania National Surveillance Data 56-98 2005 85 2009 117 (+38%)
CDC 2010 [34] Taiwan National Surveillance Data 7-67 2006 1693 2010 114 (93%)
Hammett 2010 [35] Vietnam National Surveillance Data 9-52 2005 11358 2009 7947 (30%)
  1. 1. Syringes per PWID/Year are given as a range based on the first and last date of data collection in respective study.
  2. 2. Post Implementation columns include follow-up biomarker information in addition to the difference from baseline to follow-up.